These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33632966)

  • 21. [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].
    Fallet B; Miauton A; Comte D; Ribi C; Muller YD
    Rev Med Suisse; 2021 Apr; 17(733):690-696. PubMed ID: 33830701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of vaccine development for COVID-19.
    Mendes A
    Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunization During the COVID-19 Pandemic: Recommendations From Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices.
    Kasi SG; Dhir SK; Verma S; Pemde HK; Balasubramanian S; Agarwalla S; Shah AK; Shivananda S; Marathe S; Chatarjee K; Srirampur S; Kalyani S; Parekh BJ; Basavaraja GV; Gupta P;
    Indian Pediatr; 2020 Dec; 57(12):1147-1152. PubMed ID: 33318323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building Trust to Achieve Confidence in COVID-19 Vaccines.
    Opel DJ; Salmon DA; Marcuse EK
    JAMA Netw Open; 2020 Oct; 3(10):e2025672. PubMed ID: 33079194
    [No Abstract]   [Full Text] [Related]  

  • 30. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tackling inequitable distribution of the COVID-19 vaccine.
    Mendes A
    Br J Community Nurs; 2021 Jan; 26(1):48-49. PubMed ID: 33356933
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 33. Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
    Mosina L; Külper-Schiek W; Jacques-Carroll L; Earnshaw A; Harder T; Martinón-Torres F; Wilder-Smith A; Wichmann O; Datta SS
    Vaccine; 2021 Oct; 39(45):6595-6600. PubMed ID: 34629208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. After A COVID-19 Vaccine: Collaboration Or Competition?
    Meyer H
    Health Aff (Millwood); 2020 Nov; 39(11):1856-1860. PubMed ID: 32986500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 Pandemic on Administration of Adult Vaccinations.
    Corbett S
    N C Med J; 2021; 82(2):126-129. PubMed ID: 33649129
    [No Abstract]   [Full Text] [Related]  

  • 37. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    McPartlin SO; Morrison J; Rohrig A; Weijer C
    BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 39. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
    Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.